Emel Öztürk

624 total citations
47 papers, 462 citations indexed

About

Emel Öztürk is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Emel Öztürk has authored 47 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Pathology and Forensic Medicine and 11 papers in Surgery. Recurrent topics in Emel Öztürk's work include Chemotherapy-induced organ toxicity mitigation (8 papers), Medical Imaging and Pathology Studies (7 papers) and Nigella sativa pharmacological applications (7 papers). Emel Öztürk is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (8 papers), Medical Imaging and Pathology Studies (7 papers) and Nigella sativa pharmacological applications (7 papers). Emel Öztürk collaborates with scholars based in Türkiye, Serbia and United States. Emel Öztürk's co-authors include Derya Karabulut, Ali Tuğrul Akın, Emin Kaymak, Birkan Yakan, Mehmet Özgüven, Bengül Günalp, Nuri Arslan, Hi̇kmet Bayhan, Seyfettin Ilgan and Ci̇hangi̇r Uyan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and Radiotherapy and Oncology.

In The Last Decade

Emel Öztürk

43 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emel Öztürk Türkiye 12 123 92 84 73 64 47 462
Shuo Feng China 12 36 0.3× 29 0.3× 57 0.7× 89 1.2× 91 1.4× 56 407
Shanhong Lu China 13 91 0.7× 27 0.3× 60 0.7× 93 1.3× 254 4.0× 24 647
Marilyn N. Ling United States 12 229 1.9× 52 0.6× 122 1.5× 23 0.3× 124 1.9× 23 807
Asmaa M. A. Bayoumi Egypt 13 30 0.2× 89 1.0× 38 0.5× 72 1.0× 112 1.8× 26 408
Yong Ye China 12 34 0.3× 46 0.5× 91 1.1× 305 4.2× 209 3.3× 42 611
Lucrezia Netti Italy 7 82 0.7× 45 0.5× 107 1.3× 218 3.0× 102 1.6× 15 455
Astrid Hirt Switzerland 5 48 0.4× 22 0.2× 48 0.6× 110 1.5× 137 2.1× 7 465
Vincent J. de Beer Netherlands 15 133 1.1× 50 0.5× 84 1.0× 440 6.0× 126 2.0× 30 628
Tsun-Jui Liu Taiwan 16 86 0.7× 72 0.8× 220 2.6× 324 4.4× 247 3.9× 50 800

Countries citing papers authored by Emel Öztürk

Since Specialization
Citations

This map shows the geographic impact of Emel Öztürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emel Öztürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emel Öztürk more than expected).

Fields of papers citing papers by Emel Öztürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emel Öztürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emel Öztürk. The network helps show where Emel Öztürk may publish in the future.

Co-authorship network of co-authors of Emel Öztürk

This figure shows the co-authorship network connecting the top 25 collaborators of Emel Öztürk. A scholar is included among the top collaborators of Emel Öztürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emel Öztürk. Emel Öztürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karabulut, Derya, et al.. (2023). Histopathological Changes In Lung Tissue Caused By Diabetes: A Review. Journal of Basic and Clinical Health Sciences. 7(1). 529–536.
2.
Kaymak, Emin, et al.. (2021). Protective effect of melatonin on cisplatin-induced liver injury in rats. DergiPark (Istanbul University). 4 indexed citations
3.
4.
Akın, Ali Tuğrul, et al.. (2021). Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity. The EuroBiotech Journal. 5(1). 8–14. 2 indexed citations
5.
Öztürk, Emel, et al.. (2021). Evaluation by different mechanisms of the protective effects of vitamin B12 on methotrexate nephrotoxicity. Journal of Molecular Histology. 53(1). 133–143. 7 indexed citations
6.
Karabulut, Derya, et al.. (2020). Efectos de la Melatonina Contra la Toxicidad Testicular Inducida por Tioacetamida en Ratas. International Journal of Morphology. 38(5). 1455–1462. 2 indexed citations
7.
Karabulut, Derya, et al.. (2020). Effects of vitamin B12 on methotrexate hepatotoxicity: evaluation of receptor-interacting protein (RIP) kinase. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(12). 2473–2480. 22 indexed citations
8.
Karabulut, Derya, Emel Öztürk, Emin Kaymak, Ali Tuğrul Akın, & Birkan Yakan. (2020). Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats. Journal of Biochemical and Molecular Toxicology. 35(1). e22618–e22618. 36 indexed citations
9.
Öztürk, Emel, et al.. (2020). Thymoquinone is a protective agent that reduces the negative effects of doxorubicin in rat testis. Human & Experimental Toxicology. 39(10). 1364–1373. 40 indexed citations
10.
11.
Öztürk, Emel, et al.. (2017). Does size matter? Retrospective analysis of large gynecologic tumors. Journal of the Turkish-German Gynecological Association. 18(4). 195–199.
12.
Öztürk, Emel, et al.. (2013). A synthetic approach to novel carvotacetone and antheminone analogues with anti-tumour activity. Bioorganic & Medicinal Chemistry Letters. 23(18). 5066–5069. 4 indexed citations
13.
Yüksel, Doğangün, et al.. (2005). The effects of tangential radiotherapy on lung clearance in breast cancer patients. Radiotherapy and Oncology. 77(3). 262–266. 4 indexed citations
14.
Özgüven, Mehmet, et al.. (2004). Unusual Patterns of I-131 Accumulation. Clinical Nuclear Medicine. 29(11). 738–740. 3 indexed citations
15.
Ilgan, Seyfettin, Gökçe Kaan Ataç, Nuri Arslan, et al.. (2004). Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 31(6). 825–830. 53 indexed citations
17.
Arslan, Nuri, Muhittin A. Serdar, Bekir Öztürk, et al.. (2000). Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis. Annals of Nuclear Medicine. 14(5). 395–399. 18 indexed citations
18.
Arslan, Nuri, et al.. (1999). Altered Biodistribution of Tc-99m MDP in a Uremic and Severely Malnourished Patient Supported With Enteral Nutritional Feeding. Clinical Nuclear Medicine. 24(12). 993–993. 1 indexed citations
19.
Aktolun, Cumali, Hi̇kmet Bayhan, & Emel Öztürk. (1995). Better Visualization of Retinoblastoma Metastases With Tc-99m Sestamibi Versus TI-201. Clinical Nuclear Medicine. 20(5). 446–448. 4 indexed citations
20.
Özgüven, Mehmet, et al.. (1992). Visualization of bladder diverticulum during Tc-99m DTPA renal scintigraphy. Annals of Nuclear Medicine. 6(3). 195–198. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026